Abstract
Nitric oxide has been shown to mediate beta-cell destruction in rodent islets exposed to interleukin 1β in culture. The inhibitory effect is potentiated by tumour necrosis factor-α and interferon- γ. Cytokine stimulation leads to gene transcription and translation of inducible nitric oxide synthase, the biosynthetic enzyme of nitric oxide. In the non-obese diabetic mouse, progressive invasion of pancreatic islets by immune cells may lead to local production of inflammatory cytokines, resulting in inducible nitric oxide synthase expression within the islets. In this study, the ontogeny of this enzyme and its cellular expression were examined in pancreatic sections of female non- obese diabetic mice by double-label immunofluorescence. Light and confocal microscopy were employed to study the up-regulation, co- localization and immunocytoplasmic distribution of the enzyme in female non-obese diabetic and Swiss mice following cytokine treatment. From day 40 to day 220 a small number of beta-cells and a proportion of macrophages, usually in peri-islet and exocrine areas, expressed the enzyme. At onset of diabetes, an increasing number of macrophages within and surrounding the islets were positive for the enzyme. Treatment of day 60 female non-obese diabetic mice with interleukin 1β alone and in combination with tumour necrosis factor-α and/or interferon- γ resulted in a significant influx of macrophages into the pancreas, while this was lower in female Swiss mice treated similarly. Cytokine administration led to intense but sometimes eccentric immunocytoplasmic labelling for the enzyme in a considerable proportion of macrophages and beta-cells. Macrophages positive for inducible nitric oxide synthase were located in peri- and intra-islet areas, being distal and adjacent to enzyme-positive and negative beta-cells. Treatment with tumour necrosis factor-α and/or interferon-γ did not lead to enzyme up-regulation. These results show that in the non-obese diabetic mouse there is low and sustained expression of islet inducible nitric oxide synthase in the prediabetic period, which is followed by an increase around onset. However, treatment of female non-obese diabetic and Swiss mice with interleukin- 1β, alone or together with tumour necrosis factor-α and/or interferon-γ leads to a marked expression of this enzyme within macrophages and beta-cells
Similar content being viewed by others
References
Cetkovic-Cvrlje, M. & Eizirik, D.L. (1994) TNF-· and IFN-· potentiate the deleterious effects of IL-1· on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine6, 399-406.
Chesrown, S.E., Monnier, J., Visner, G. & Nick, H.S. (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-·, TGF-· and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun.200, 126-34.
Corbett, J.A., Mikhael, A., Shimizu, J., Frederick, K., Misko, T.P., Mcdaniel, M.L., Kanagawa, O. & Unanue, E.R. (1993a) Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and-resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA90, 8992-5.
Corbett, J.A., Sweetland, M.A., Wang, J.L., Lancaster, J.R. & Mcdaniel, M.L. (1993b) Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA90, 1731-5.
Corbett, J.A. & Mcdaniel, M.L. (1995) Intraislet release of interleukin 1 inhibits · cell function by inducing · cell expression of inducible nitric oxide synthase. J. Exp. Med.181, 559-68.
Corbett, J.A., Wang, J.L., Sweetland, M.A., Lancaster, J.R. & Mcdaniel, M.L. (1992) Interleukin 1· induces the formation of nitric oxide by ·-cells purified from rodent islets of Langerhans. Evidence for the ·-cell as a source and site of action of nitric oxide. J. Clin. Invest.90, 2384-91.
Dunger, A., Cunningham, J.M., Delaney, C.A., Lowe, J.E., Green, M.H.L., Bone, A.J. & Green, I.C. (1996) Tumour necrosis factor-· and interferon-· inhibit insulin secretion and cause DNA damage in unweaned-rat islets: extent of nitric oxide involvement. Diabetes45, 183-9.
Eizirik, D.L., Bjorklund, A. & Welsh, N. (1993) Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett.317, 62-6.
Held, W., Macdonald, H.R., Weissman, I.L., Hess, M.W. & Mueller, C. (1990) Genes encoding tumour necrosis factor · and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA87, 2239-43.
Hibbs, J.B., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R.L., Ward, J.H., Menlove, R.L., Mcmurry, M.P., Kushner, J.P. & Samlowski, W.E. (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest.89, 867-77.
Holstad, M. & Sandler, S. (1993) Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycaemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity15, 311-14.
Hukkanen, M., Hughes, F.J., Buttery, L.D.K., Gross, S.S., Evans, T.J., Seddon, S., Riveros-Moreno, V., Macintyre, I. & Polak, J.M. (1995) Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology136, 5445-53.
Jafarian-Tehrani, M., Amrani, A., Homo-Delarche, F., Marquette, C., Dardenne, M. & Haour, F. (1995) Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice. Endocrinology136, 609-13.
Jansen, A., Cook, T., Taylor, G.M., Largen, P., Riveros-Moreno, V., Moncada, S. & Cattell, V. (1994) Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int.45, 1215-19.
Jiang, Z. & Woda, B.A. (1991) Cytokine gene expression in the islets of the diabetic biobreeding/Worcester rat. J. Immunol.146, 2990-4.
Kallmann, B., Burkart, V., Kroncke, K-D., Kolb-Bachoven, V. & Kolb, H. (1992) Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci.51, 671-8.
Kaneto, H., Fujii, J., Seo, H.G., Suzuki, K., Matsuoka, T-A., Nakamura, M., Tatsumi, H., Yamasaki, Y., Kamada, T. & Taniguchi, N. (1995) Apoptic cell death triggered by nitric oxide in pancreatic ·-cells. Diabetes44, 733-8.
Karlsen, A.E., Andersen, H.U., Vissing, H., Larsen, P.M., Fey, S.J., Cuartero, B.G., Madsen, O.D., Petersen, J.S., Mortensen, S.B., Mandrup-Poulsen, T., Boel, E. & Nerup, J. (1995) Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes44, 753-8.
Kasai, K., Hattori, Y., Nakanishi, N., Manaka, K., Banba, N., Motohashi, S. & Shimoda, S.I. (1995) Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinology136, 4261-70.
Kleemann, R., Rothe, H., Kolb-Bachofen, V., Xie, Q-W., Nathan, C., Martin, S. & Kolb, H. (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett.328, 9-12.
Kolb, H., Kiesel, V., Kroncke, K-D. & Kolb-Bachoven, V. (1991) Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci.49, 213-17.
Kroncke, K., Steiner, L., Fehsel, K. & Kolb-Bachofen, V. (1995) Cytokine-activated capillary-forming islet endothelial cells lyse beta-cells via nitric oxide generation. Autoimmunity21, 42.
Lindsay, R.M., Smith, W., Rossiter, S.P., Mcintyre, M.A., Williams, B.C. & Baird, J.D. (1995) N·-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes44, 365-8.
Lukic, M.L., Stosic-Grujucic, S., Ostojic, N., Chan, W.L. & Liew, F.Y. (1991) Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun.178, 913-20.
Macmicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., Stevens, K., Xie, Q-W., Sokol, K., Hutchinson, N., Chen, H. & Mudgett, J.S. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell81, 641-50.
Mandrup-Poulsen, T., Helqvist, S., Molvig, J., Wogensen, L.D. & Nerup, J. (1989) Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity4, 191-218.
Mandrup-Poulsen, T., Helqvist, S., Wogensen, L.D., Molvig, J., Pociot, F., Johannesen, J. & Nerup, J. (1990) Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. In Human Diabetes — Genetic, Environmental and Autoimmune Etiology. (edited by Baekkeskov, S. & Hansen, B.) pp. 169-93. Heidelberg: Springer-Verlag.
Moncada, S., Palmer, R.M.J. & Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev.43, 109-42.
Pipeleers, D.G. (1992) Heterogeneity in pancreatic ·-cell population. Diabetes41, 777-81.
Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, O. & Bleackley, R.C. (1996) Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS expressing cells and relationships to cytokines expressed in the islets. Endocrinology137, 2093-9.
Reddy, S., Bibby, N.J. & Elliott, R.B. (1988) Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia31, 322-8.
Reddy S., Liu, W. & Elliott, R.B. (1993) Distribution of pancreatic macrophages preceding and during insulitis in young NOD mice. Pancreas8, 602-8.
Reddy, S., Salari-Lak, N. & Sandler, S. (1995a) Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1·. Endocrinology136, 1907-12.
Reddy, S., Wu, D., Swinney, C. & Elliott, R.B. (1995b) Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas11, 16-25.
Reddy, S., Wu, D. & Polle, C.A. (1996) Glutamic acid decarboxylase 65 and 67 isoforms in fetal, neonatal and adult porcine islets: predominant beta cell colocalization by light and confocal microscopy. J. Autoimmun.9, 21-7.
Rothe, H., Faust, A., Schade, U., Kleemann, R., Bosse, G., Hibino, T., Martin, S. & Kolb, H. (1994) Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia37, 1154-8.
Sandler, S., Andersson, A. & Hellerstrom, C. (1987) Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology121, 1424-31.
Sandler, S., Eizirik, D.L., Svensson, C., Strandell, E., Welsh, M. & Welsh, N. (1991) Biochemical and molecular actions of interleukin-1 on pancreatic ·-cells. Autoimmunity10, 241-53.
Signore, A., Pozzilli, P., Gale, E.A.M., Andreani, D. & Beverley, P.C.L. (1989) The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia32, 282-9.
Southern, C., Schulster, D. & Green, I.C. (1990) Inhibition of insulin secretion by interleukin-1· and tumour necrosis factor-· by an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett.276, 42-4.
Sternesjo, J., Bendtzen, K. & Sandler, S. (1995) Effects of prolonged exposure in vitro to interferon-· and tumour necrosis factor-· on nitric oxide and insulin production of rat pancreatic islets. Autoimmunity20, 185-90.
Suarez-Pinzon, W.L., Strynadka, K., Schulz, R. & Rabinovitch, A. (1994) Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology134, 1006-10.
Weir, G.C. & Bonner-Weir, S. (1990) Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J. Clin. Invest.85, 983-7.
Welsh, N., Eizirik, D.L., Bendtzen, K. & Sandler, S. (1991) Interleukin-1· induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme, aconitase. Endocrinology129, 3167-73.
Welsh, N., Eizirik, D.L. & Sandler, S. (1994) Nitric oxide and pancreatic ·-cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer. Autoimmunity18, 285-90.
Welsh, M., Welsh, N., Bendtzen, K., Mares, J., Strandell, E., Oberg, C. & Sandler, S. (1995) Comparison of mRNA contents of interleukin-1· and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetologia38, 153-60.
Whittle, B.J.R. (1995) Nitric oxide in physiology and pathology. Histochem. J.27, 727-37.
Wu, G. (1995) Nitric oxide synthesis and the effect of aminoguanidine and N-G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes44, 360-4.
Xie, Q-W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T. & Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science256, 225-8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reddy, S., Kaill, S., Poole, C.A. et al. Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration. J Mol Hist 29, 53–64 (1997). https://doi.org/10.1023/A:1026416918339
Issue Date:
DOI: https://doi.org/10.1023/A:1026416918339